These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 37778903)

  • 41. What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study.
    De Vito A; Colpani A; Poliseno M; Diella L; Ieva FRP; Belati A; Papale R; Babudieri S; De Santis L; Saracino A; Lo Caputo S; Madeddu G
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond.
    Dhama K; Patel SK; Kumar R; Rana J; Yatoo MI; Kumar A; Tiwari R; Dhama J; Natesan S; Singh R; Harapan H
    Front Public Health; 2020; 8():574198. PubMed ID: 33072713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
    Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
    Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.
    Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS
    JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020.
    Viera-Segura O; Vega-Magaña N; García-Chagollán M; Peña-Rodríguez M; Muñoz-Sánchez G; Carranza-Aranda AS; Llamas-Covarrubias IM; Ramos-Solano M; Mora-Mora J; Díaz-Palomera CD; León GE; Zepeda-Nuño JS; Santillán-López E; García-Arellano S; Hernández-Silva CD; Zerpa-Hernandez DA; Muñoz-Rios G; Rodríguez-Sanabria JS; Muñoz-Valle JF
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].
    Yürüker Ö; Yetkin O; Güvenir M
    Mikrobiyol Bul; 2023 Apr; 57(2):330-333. PubMed ID: 37067217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.
    Itamochi M; Yazawa S; Inasaki N; Saga Y; Yamazaki E; Shimada T; Tamura K; Maenishi E; Isobe J; Nakamura M; Takaoka M; Sasajima H; Kawashiri C; Tani H; Oishi K
    Vaccine; 2023 Mar; 41(13):2234-2242. PubMed ID: 36858871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effectiveness of vaccination for preventing hospitalisation with COVID-19 in regional Queensland: a data linkage study.
    Smoll NR; Al Imam MH; Shulz C; Booy R; Khandaker G
    Med J Aust; 2023 Aug; 219(4):162-165. PubMed ID: 37400415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
    Baden LR; El Sahly HM; Essink B; Kotloff K; Frey S; Novak R; Diemert D; Spector SA; Rouphael N; Creech CB; McGettigan J; Khetan S; Segall N; Solis J; Brosz A; Fierro C; Schwartz H; Neuzil K; Corey L; Gilbert P; Janes H; Follmann D; Marovich M; Mascola J; Polakowski L; Ledgerwood J; Graham BS; Bennett H; Pajon R; Knightly C; Leav B; Deng W; Zhou H; Han S; Ivarsson M; Miller J; Zaks T;
    N Engl J Med; 2021 Feb; 384(5):403-416. PubMed ID: 33378609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington.
    Roxby AC; Greninger AL; Hatfield KM; Lynch JB; Dellit TH; James A; Taylor J; Page LC; Kimball A; Arons M; Munanga A; Stone N; Jernigan JA; Reddy SC; Lewis J; Cohen SA; Jerome KR; Duchin JS; Neme S
    JAMA Intern Med; 2020 Aug; 180(8):1101-1105. PubMed ID: 32437547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis.
    Anderegg N; Panczak R; Egger M; Low N; Riou J
    BMC Med; 2022 Apr; 20(1):164. PubMed ID: 35468785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Companion animals likely do not spread COVID-19 but may get infected themselves.
    Csiszar A; Jakab F; Valencak TG; Lanszki Z; Tóth GE; Kemenesi G; Tarantini S; Fazekas-Pongor V; Ungvari Z
    Geroscience; 2020 Oct; 42(5):1229-1236. PubMed ID: 32766998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study.
    Hua Q; Zhang H; Yao P; Xu N; Sun Y; Lu H; Xu F; Liao Y; Yang J; Mao H; Zhang Y; Zhu H; Hu X; Lv H; Jiang J
    Front Immunol; 2022; 13():939311. PubMed ID: 36032136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak.
    Blain H; Gamon L; Tuaillon E; Pisoni A; Giacosa N; Albrand M; Miot S; Rolland Y; Picot MC; Bousquet J
    Age Ageing; 2021 May; 50(3):641-648. PubMed ID: 33620381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
    Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
    Front Public Health; 2021; 9():689919. PubMed ID: 34222187
    [No Abstract]   [Full Text] [Related]  

  • 58. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
    Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC;
    JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population.
    Ciabattini A; Garagnani P; Santoro F; Rappuoli R; Franceschi C; Medaglini D
    Semin Immunopathol; 2020 Oct; 42(5):619-634. PubMed ID: 33159214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of COVID-19 vaccines and major considerations for diabetic patients.
    Soltani S; Zandi M; Shiri Aghbash P; Rezaei M; Mohammadzadeh N; Afsharifar A; Poortahmasebi V
    Biotechnol Appl Biochem; 2022 Feb; 69(1):30-40. PubMed ID: 33179788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.